Growth factors and craniofacial surgery

The Journal of Craniofacial Surgery
Pedro AlvarezJeffrey O Hollinger

Abstract

The specialty of craniofacial surgery is broad and includes trauma, aesthetics, reconstruction of congenital deformities, and regeneration of tissues. Moreover, craniofacial surgery deals with a diverse range of tissues including both "soft" and "hard" tissues. Technological advances in materials and biological sciences and improved surgical techniques have remarkably improved clinical outcomes. The quest to raise the bar for patient care continues to inspire advances for predictable biological regeneration of soft and hard tissues. As a consequence of this quest for advancement, a wide spectrum of biologicals is becoming available to surgeons. Is the use of recombinant DNA engineered biologicals daring? Sensible? Logical? Timely? Safe? It is crucial for the practicing craniofacial surgeon to take a step back periodically and carefully review the biological factors that have the potential for dramatically altering the discipline of craniofacial surgery. With this emphasis, the coauthors of this article will focus on growth factor technology underscoring bone tissue regeneration. As the 21st-century matures, recombinant human biologicals will have an overwhelming impact on the practice of craniofacial surgery.

References

Nov 12, 1965·Science·M R Urist
Oct 3, 1999·Physiological Reviews·C H Heldin, B Westermark
Sep 3, 2002·Spine·John M Wozney
Nov 7, 2002·International Journal of Oral and Maxillofacial Surgery·H Schilephake
Dec 6, 2002·Endocrine Reviews·Hua ChangMartin M Matzuk
Apr 18, 2003·Endocrine Reviews·Ernesto CanalisElisabetta Gazzerro
Apr 23, 2003·Implant Dentistry·Charles A BabbushMay S Jacobson
Apr 16, 2004·Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons·Robert E Marx
Apr 28, 2004·The Journal of Craniofacial Surgery·Troels T Andreassen, Vittorio Cacciafesta
Oct 29, 2004·Plastic and Reconstructive Surgery·Barry L EppleyJoel Higgins
Jan 21, 2006·The Journal of Endocrinology·John T Potts
Oct 20, 2006·Plastic and Reconstructive Surgery·Barry L EppleyMatthew Blanton
Mar 20, 2008·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Gary G Schwartz
Jul 9, 2008·Biotechnology Annual Review·Huub Schellekens
Nov 20, 2008·Archives of Facial Plastic Surgery·Abel-Jan Tasman, Pietro Palma
Nov 20, 2008·Archives of Facial Plastic Surgery·Sherard A Tatum, William D Losquadro
Jun 9, 2009·Biotechnology Advances·Arnold L Demain, Preeti Vaishnav
Jul 31, 2009·Journal of Dental Research·E L Scheller, P H Krebsbach
Feb 18, 2010·Oral and Maxillofacial Surgery Clinics of North America·Sarah D Davies, Mark W Ochs
Aug 7, 2010·Cytokine & Growth Factor Reviews·Ashok Singh, Rebecca J Morris
Oct 20, 2010·The Journal of Pathology·Erik Meulmeester, Peter Ten Dijke

❮ Previous
Next ❯

Citations

Oct 29, 2013·TheScientificWorldJournal·Yukihiko Kinoshita, Hatsuhiko Maeda
Sep 19, 2015·AAPS PharmSciTech·Pedro Henrique Justino Oliveira LimirioPaula Dechichi
Aug 24, 2018·Frontiers in Physiology·Giovanna OrsiniThimios A Mitsiadis
Aug 28, 2020·Tissue Engineering. Part a·Chen ShenSimon Young

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.